about
Nomenclature of human platelet antigens348 cases of suspected neonatal alloimmune thrombocytopeniaHeparin-associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological crossreactivity between heparin and polysulphated glycosaminoglycanSurface Modification of Biodegradable Polymers towards Better Biocompatibility and Lower Thrombogenicity348 CASES OF SUSPECTED NEONATAL ALLOIMMUNE THROMBOCYTOPENIAA point mutation Thr(799)Met on the alpha(2) integrin leads to the formation of new human platelet alloantigen Sit(a) and affects collagen-induced aggregation.Thrombocytopenic purpura: adverse reaction to a combined immunisation (recombinant hepatitis B and measles-mumps-rubella-vaccine) and after therapy with Co-trimoxazole.Single amino acid substitution in human platelet glycoprotein Ibbeta is responsible for the formation of the platelet-specific alloantigen Iy(a).Platelet alloantibodies in transfused patients.Drug-induced and drug-dependent immune thrombocytopenias.Human platelet alloantigens.A functional platelet fibrinogen receptor with a deletion in the cysteine-rich repeat region of the beta(3) integrin: the Oe(a) alloantigen in neonatal alloimmune thrombocytopenia.[Detection of platelet-specific alloantigens in 400 unselected blood donors][Clinical and serologic studies in 34 patients with post-transfusion purpura][Neonatal isoimmune thrombocytopenia by anti-GP IIb/IIIa][Prevalence of lupus anticoagulant, autoimmune hemolysis, thrombocytopenia and disorders of platelet function in unselected patients with SLE]Anti-HPA-4b (anti-Yuk(a)) neonatal alloimmune thrombocytopenia: first report in a Caucasian family.May-Hegglin anomaly: a rare cause of thrombocytopenia.Serological, biochemical, and molecular aspects of platelet autoantigens.Anti-HPA-1a in a case of post-transfusion purpura: binding to antigen-negative platelets detected by adsorption/elution.Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT).[The Br(a)/Br(b) alloantigen system in thrombocytes][Sr(a), a "private" thrombocyte alloantigen as a cause of neonatal alloimmune thrombocytopenia][Serologic characterization of platelet-associated IgG and its significance for the diagnosis of thrombocytopenias][219 Zw(a) positive mothers of children with clinically suspected neonatal alloimmune thrombocytopenia]Autoantibodies against platelet glycoprotein Ib/IX: a frequent finding in autoimmune thrombocytopenic purpura.A systematic review and survey of the management of unexpected neonatal alloimmune thrombocytopenia.A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia.Management of alloimmune thrombocytopenia.HPA-5b (Br(a)) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases.High-dose intravenous gammaglobulin for neonatal alloimmune thrombocytopenia in twins.[Diagnosis and therapy of autoimmune thrombocytopenia. Recommendations of a joint Expert Group of DGHO, DGTI, DTH].[Differential diagnosis and treatment of thrombocytopenia].Review and update of platelet alloantigen systems.Reactions Induced by Platelet Transfusions.Sra, a private platelet antigen on glycoprotein IIIa associated with neonatal alloimmune thrombocytopenia.Management of infants born with severe neonatal alloimmune thrombocytopenia: the role of platelet transfusions and intravenous immunoglobulin.[Characterization of thrombocyte autoantibodies using monoclonal antibodies]The Bra/Brb alloantigen system on human platelets.[Thrombocyte-specific antigens/antibodies and their clinical importance]
P50
Q28205492-74D8AD3A-6048-498B-B535-B92B9AF30DC3Q28256185-34C6686F-1E50-4095-B64F-A09BC26A7415Q28316497-08876ED6-2784-4E9E-8268-7284CAAED899Q28551353-6C7D5AC5-BEB4-4AA4-A4EF-15BDB98175DFQ29012672-217BEE18-D058-41D3-8923-F416CE91F415Q33330853-F89363E1-FA98-49BF-99C1-B93DBA0E008DQ33331332-C7EDA5F3-CDE1-4808-92E7-5ECE568E3A20Q33331582-6515CA2F-53C5-4F25-AE3E-7DE6C0CCA059Q33337692-AFDB4871-B7AD-4F9D-984F-B03E85713E37Q33339739-BE2AB028-951D-4632-80CF-A1C37F4A37FEQ33340053-5CFAD631-73FB-4523-BE35-CAA4C8A02EC8Q33340927-5997BEA8-E784-4B7D-8FCA-1290F76711F4Q33348858-669C1E80-FEBD-484F-8208-5629772E16BEQ33348861-E0791265-6DBE-49BF-BE2E-4DB859B8E86EQ33348870-9D0F6EC7-0AD0-400E-878C-E732C72E5504Q33348873-75459C2E-2D2F-48C2-866A-F33B91A1F718Q33351612-C6558805-BBAE-477E-8FC3-C0982E7C8738Q33353880-C29A9E6D-124B-4852-B5C6-3505C738C6D7Q33364922-5542415A-C82A-4B67-97A2-4AE986150594Q33366689-B6EDAD15-1AE6-4014-B63E-86BE288F12A6Q33369845-9CD9FBCC-F0EA-42CF-833F-AE5DDBFFB22BQ33372965-DB25C3F3-735A-497D-BDC0-A4A4B8438346Q33372967-50F56A73-D779-4790-846F-A506527F7B0EQ33372969-DDE48ADD-8152-45E2-85F2-5C31952F32FCQ33372971-AE31EFA0-9695-4456-A8FB-A0DE54B22AF8Q33373750-0FA5DD49-785C-45C0-A4DC-D8310CAEEAF7Q33376796-6CAFAD4B-2E13-4D44-8139-A7286BF9F7F6Q33377166-560072BD-C3FA-47D6-80F5-A2B7EBF7FAFEQ33377740-C7CF5C7F-D3F2-419D-A465-FB1B1248282CQ33380911-5E3FEF61-6A3D-4ED9-8013-769BF7A90EB8Q33388755-D1593C39-9A5F-4821-A48B-BCC5B9899B5DQ33389683-CD436B91-5259-4661-A53D-C5A493868A2EQ33392258-34E928E2-C7EC-46DE-A544-FA11DC2ACD20Q33394294-45063C8D-C579-4B7C-8291-516CB418339EQ33395008-379D2C69-368B-42BB-BDCB-2145B7B789EAQ33401144-BC19FC56-B409-4427-9BDD-F6BD08A0E431Q33409227-65C65C75-B64F-4DBC-A60E-E6C1425F766BQ33413940-7CF1C9C4-9275-4240-8B11-F1AF2D6A0F02Q33414520-36FA9DB8-ABD0-4452-9E44-93546481A4B3Q33415200-7A726E96-B1D5-4279-AD14-6B01A3BB4DA5
P50
description
deutscher Transfusionsmediziner
@de
name
Volker Kiefel
@ast
Volker Kiefel
@de
Volker Kiefel
@en
Volker Kiefel
@nl
Volker Kiefel
@sl
type
label
Volker Kiefel
@ast
Volker Kiefel
@de
Volker Kiefel
@en
Volker Kiefel
@nl
Volker Kiefel
@sl
altLabel
Kiefel V
@en
Kiefel V.
@en
Kiefel
@en
V Kiefel
@en
V. Kiefel
@en
prefLabel
Volker Kiefel
@ast
Volker Kiefel
@de
Volker Kiefel
@en
Volker Kiefel
@nl
Volker Kiefel
@sl
P214
P227
P106
P21
P213
0000 0000 7294 8846
P214
P227
P2940
P31
P7859
viaf-102504329